Hologic, Inc.

NASDAQ:HOLX   3:59:55 PM EDT
76.07
-0.08 (-0.10%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)19.13B
Current PE10.23
Forward PE 20.45
2yr Forward PE 19.71
See more stats
Estimates Current Quarter
Revenue$1.12 Billion
Adjusted EPS$1.21
See more estimates
10-Day MA$74.84
50-Day MA$72.65
200-Day MA$71.51
See more pivots

Hologic, Inc. Stock, NASDAQ:HOLX

250 Campus Drive, Marlborough, Massachusetts 01752
United States of America
Phone: +1.508.263.2900
Number of Employees: 6705

Description

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products dedicated to serve the healthcare needs of women. It operates through the following segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. The Breast Health segment includes a portfolio of solutions for breast cancer care for radiology, pathology, and surgery. The Diagnostics segment comprises products used to aid in the screening and diagnosis of human diseases. The GYN Surgical segment involves the NovaSure Endometrial Ablation System, the MyoSure Hysteroscopic Tissue Removal System, and the Fluent Fluid Management System. The Skeletal Health segment covers the Horizon DXA and the Fluoroscan Insight FD mini C-arm. The company was founded by S. David Ellenbogen and Jay A. Stein in 1985 and is headquartered in Marlborough, MA.